![]() Press Release Distribution |
influenza News+ XML/RSSBy KMR-Media LLC On Thursday morning January 19th, 2012 on air radio personality, Ray Leonard was rushed by ambulance in Wyoming, Michigan to the Metro Health Emergency Room around 12 pm. By Alexandra hichel For Michigan residents, influenza peaks between February and March. The Visiting Nurse Association of Southeast Michigan (VNA) reminds businesses to prepare their employees for the flu through workplace hygiene tips and onsite flu immunizations. By Florida Hospital Oceanside On Tuesday, November 8, 127 community members came to Florida Hospital Oceanside for a free influenza "flu" vaccine. By Insight Pharma Reports New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects By Dan Aronovic BiondVax Announces Receipt of IRB Ethics (“Helsinki”) Committee Approvals for the Initiation of Second Phase II Clinical Trial for Universal Influenza Vaccine. The trial will start in October 2011 with 120 participants over the age of 65. By Simon Campbell “the annual influenza season has started with cases being reported since the first week in May and a sharp rise in the past week.” By Dr.Victor Marchione Part two of the article series on your immune system focuses in on changes that can occur as we age. It's important to know what can happen, and what can further weaken your immune system. Let's get to it. Preparing for next round of pandemic influenza should be priority for healthcare authorities in MENA By Informa Exhibitions Experts at Abu Dhabi Medical Congress to discuss challenges of working with infection prevention and control By Danny Aronovic, Shapira Marketing BiondVax Pharmaceuticals Ltd. is pleased to announce that the company's Chief Scientific Officer, Dr. Tamar Ben-Yedidia, will present the results of the Phase IIa clinical trial on the universal flu vaccine at the 2011 BIO International Convention. By Influenza Virus Net Influenza information collected on comprehensive website Influenza Virus Net By FEBICO (Far East Bio-Tech Co., Ltd.) Apogen Capsules provide sufficient nutrition sources such as, vitamin B group, essential amino acids, trace elements, etc., to balance the required nutritions the body needs even on a busy day. By polyDNA Green Tea has many benefits: one is to suppress the Influenza Virus. Its active components of polyphenols and catechins have proven to be potent in fighting the influenza virus. By polyDNA The obese are more at risk of a number of ailments and need added antiviral protection. Three basic options exist for obese people seeking additional treatment and protection: vaccines, antiviral medications, and health supplements. By polyDNA Quercetin has been found to be an effective tool for fighting the flu virus. Protect against the common cold and flu with Gene-Eden, a natural supplement that contains this plant-derived flavonoid. By polyDNA Researchers discovered that quercetin, a plant-derived flavonoid, helps prevent or counter the influenza virus. A great method for consuming quercetin is Gene-Eden, a natural antiviral health supplement designed to fight influenza and other viruses. By polyDNA Swine flu is a major danger to public health in 2011. There are three basic options for treating influenza: antiviral medication, antiviral supplements, and vaccine. By polyDNA Swine flu infections across the globe; Three options available to protect against H1N1 swine flu By polyDNA Mutation of H5N1 virus could lead to worldwide pandemic; important to public to know health options. By polyDNA Researchers discovered that quercetin, a plant-derived flavonoid, helps prevent & counter the influenza virus. A great method for consuming quercetin is Gene-Eden, a natural antiviral health supplement designed to fight influenza and other viruses. By Total Quality Cleaning Systems With the flu season hitting its stride, it is important for businesses to prepare for the health and economic impact on their employees and the company's bottom line. Learn 8 easy steps which can help to lessen the effect of the flu on your company. By American Lung Association of the Upper Midwest New report shows adults 65 and over are not getting vaccinated, especially African Americans & Hispanics By EggFreeEpicurean.com Amy Jones Anichini, mother of a girl with a food allergy to eggs, reports on her daughter getting her first flu shot since being diagnosed has having an egg allergy. By sandlerresearch GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Influenza Vaccines By sandlerresearch GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Influenza Vaccines By Don Smith Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with influenza. By PolyDNA Half a million people die of the Flu each year. Recent research shows that Quercetin can combat the Flu. Quercetin, as well as four other anti-viral ingredients, is found in Gene-Eden. Reduce your chances of contracting the Flu by trying Gene-Eden. By Danny Aronovic BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company developing a Universal Influenza Vaccine, today announced that it has raised $1.25 million under its Standby Equity Distribution Agreement (SEDA) with YA Global Investments L.P. By Danny Aronovic Dr. Tamar Ben-Yedidia will be presenting at the Influenza Congress USA next week in Washington, D.C. BiondVax is currently in Phase IIa clinical trials (human subjects) for its Universal Influenza Vaccine. By BC Pharmacy Association As British Columbians get ready for flu season, the BC Pharmacy Association is reminding patients that they can get their seasonal vaccination from their pharmacist. By reports-research.com GlobalData, the industry analysis specialist, has released its new report, Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Influenza Vaccines market. By Danny Aronovic Dr. Tamar Ben-Yedidia will be speaking at the upcoming World Vaccine Congress in Lyon, France on October 4, 2010. She will be updating the congress on the company's progress and upcoming Phase II trials starting in October. BiondVax Announces Approvals for Initiation of First Phase II Trials for Universal Influenza Vaccine By Danny Aronovic BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine By Justin Handy EBS and TLV announced their agreement to form EPIC BIO, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused. By Ana Laura Berdugo The Pilgrimage to Cartago where thousands of Costa Ricans walk every year since 1781 to the Basilica of the Angels to bring in their petitions has its virtual version for two consecutive years. By Danny Aronovic According to Frost & Sullivan, BiondVax is the leading company in the quest for the universal influenza vaccine and has received Frost & Sullivan’s 2010 European Influenza Vaccines Technology Innovation Award. By reports-research.com According to media reports, pharmaceutical company Abbott Laboratories is looking to auction off its influenza vaccine business in a deal that could be worth up to $600m. By Dan Aronovic Chief Scientific Officer, Dr. Tamar Ben Yedidia, will provide an overview of the Company's technology and clinical development progress at two upcoming biopharma industry conferences in Israel and Barcelona, Spain By Megan Hasten, Integress Meetings and Events In the wake of an influenza pandemic, an international conference provides opportunities to mitigate ideas and solutions across industries. By Dan Aronovic BiondVax receives funding based on their work on a Universal Flu Vaccine, receiving an additional $1 Million of funding from the Israel Chief Scientist’s office and signing of the final agreement with Yorkville Advisors for $7m By Chris Norman Belonging to the list of the most common diseases affecting mankind is flu. And oddly enough, every time it strikes humanity, it does so with a force even greater than its previous rampage. By Blackboard Inc. Personal Message From CDPH Director Urges Flu Prep in Schools, on Campus By Michelle Roberts, Director of Communication Winter is winding down, spring is around the corner, and news about the H1N1 flu virus has just about disappeared from the news. So after all the stories about vaccine shortages and fears of a pandemic, what was the final tally in Missouri? By Dan Aronovic BiondVax Reports Positive Interim Safety Results from Second Phase I/II Universal Influenza Vaccine Trial BiondVax’s Multimeric-001 Universal Flu Vaccine Shown to be Safe and Well Tolerated in trial of 60 elderly participants By Bharatbook Bharatbook added a new report on "Influenza Vaccine Market Outlook 2010-2020" provides detailed sales forecasts, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. By GlobalData Influenza Vaccines Market is forecast to Show High Growth till 2016. By Askin Ozcan Pros and cons of the swine flu vaccin puzzles everyone. But, more so, author Askin Ozcan, as he is refused vaccination against the swine flu in a Stockholm clinic. By Jason Principe School battles the flu with lotus chemical-free cleaning technology. By Green Earth Nano Science, Inc. (PCO) Photo-Catalytic Oxidation Technology recommended by Environmental Protection Agency (EPA) as one of proven systems to fight H1N1 Swine Flu in clean rooms, commercial and residential indoor environments. Asthmatics at Severe Risk for Flu, H1N1 - Vaccination urged by American Lung Assn in Greater Chicago By American Lung Association in Greater Chicago New CDC Report States 32% of 2009 H1N1 Hospitalizations Were Asthmatics |
|